...
首页> 外文期刊>Cephalalgia >Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.
【24h】

Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.

机译:在一个专门的头痛中心治疗药物过度使用性头痛和慢性偏头痛:实地测试提出了新的附录标准。

获取原文
获取原文并翻译 | 示例
           

摘要

The classification subcommittee of the International Headache Society (IHS) has recently suggested revised criteria for medication overuse headache (MOH) and chronic migraine (CM). We field tested these revised criteria by applying them to the headache population at the Danish Headache Centre and compared the results with those using the current criteria. For CM we also tested two alternative criteria, one requiring > or = 4 migraine days/month and > or = 15 headache days/month, the second requiring > or = 15 headache days/month and > or = 50% migraine days. We included 969 patients with migraine or tension-type headache (TTH) among 1326 patients treated and dismissed in a 2-year period. Two hundred and eighty-five patients (30%) had TTH, 265 (27%) had migraine and 419 (43%) had mixed migraine and TTH. The current criteria for MOH classified 86 patients (9%) as MOH, 98 (10%) as probable MOH and 785 (81%) as not having MOH after a 2-month drug-free period. Using the appendix criteria, 284 patients (29%)were now classified as MOH, no patients as probable MOH and 685 (71%) as not having MOH. For CM only 16 patients (3%) fulfilled the current diagnostic criteria. This increased to 42 patients (7%) when we applied the appendix criteria. Using the less restrictive criteria of > or = 4 migraine days and > or = 15 headache days, 88 patients (14%) had CM, whereas the more restrictive criteria of > or = 15 headache days and > or = 50% migraine days resulted in 24 patients (4%) with CM. Our data suggest that the IHS has succeeded in choosing new criteria for CM which are neither too strict, nor too loose. For MOH, a shift to the appendix criteria will increase the number of MOH patients, but take into account the possibility of permanent changes in pain perception due to medication overuse and the possibility of a renewed effect of prophylactic drugs due to medication withdrawal. We therefore recommend the implementation of the appendix criteria for both MOH and CM into the main body of the International Classification of Headache Disorders.
机译:国际头痛协会(IHS)的分类小组委员会最近建议修订药物过度使用性头痛(MOH)和慢性偏头痛(CM)的标准。我们通过将这些修订的标准应用于丹麦头痛中心的头痛人群,对这些修订的标准进行了现场测试,并将结果与​​使用当前标准的结果进行了比较。对于CM,我们还测试了两个替代标准,一个标准要求>或= 4偏头痛天/月和>或= 15头痛日/月,第二个标准要求>或= 15头痛日/月和>或= 50%偏头痛。我们纳入了在2年内接受治疗并解散的1326例患者中的969例偏头痛或紧张型头痛(TTH)患者。 285名患者(30%)患有TTH,265名(27%)患有偏头痛,419名(43%)患有偏头痛和TTH混合。在两个月的无药期后,当前的MOH标准将86例(9%)分为MOH,98例(10%)归为可能的MOH,将785例(81%)归为MOH。使用附录标准,现在将284例患者(29%)归为MOH,没有患者被归为可能的MOH,而685例患者(71%)被归为没有MOH。对于CM,只有16名患者(3%)符合当前的诊断标准。当我们应用阑尾标准时,这一数字增加到42例(7%)。使用限制较小的标准,即>或= 4偏头痛天和>或= 15头痛日,有88例患者(14%)患有CM,而使用限制性更强的标准或= 15头痛天且>或= 50%偏头痛天在24例CM患者中(4%)。我们的数据表明,IHS已成功为CM选择了既不严格也不过于宽松的新标准。对于MOH,转移到附录标准将增加MOH患者的数量,但要考虑到过度用药可能导致永久性的疼痛感改变,以及因停药而产生的预防性药物重新产生作用的可能性。因此,我们建议将国际卫生部和医学部附录标准的实施纳入《国际头痛分类》的主体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号